SCHEMBL26110418

SCHEMBL26110418

CCCCOC(=O)N1CCN(c2cccc3c2n(C)c(=O)n3COCC[Si](C)(C)C)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
GAA P10253 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CXCR3 P49682 1/20 0.37
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NPC1 O15118 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ADORA2A P29274 2/20 0.34
ADORA2B P29275 2/20 0.34
PLA2G2A P14555 2/20 0.34
OPRD1 P41143 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23536299 0.87 TP53 (0.39) MAPTLMNANPC1OPRD1
SCHEMBL25336947 0.86 NPC1 (0.39) ALDH1A1MAPTSMN1; SMN2CXCR3LMNA
SCHEMBL13015494 0.80 DPP4 (0.38) ALDH1A1MAPTSMN1; SMN2LMNAMEN1
SCHEMBL31407899 0.80 KMT2A (0.32) ALDH1A1SMN1; SMN2LMNAPOLBMEN1
SCHEMBL23536489 0.80 CYP11B2 (0.39) NPC1OPRD1OPRK1
SCHEMBL25340473 0.80 DPP4 (0.39) ALDH1A1MAPTSMN1; SMN2L3MBTL1NPC1
SCHEMBL31726831 0.78 CYP11B2 (0.38)
SCHEMBL23536426 0.77 CYP11B2 (0.40) NPC1
SCHEMBL25338150 0.75 BACE1 (0.32) MAPTLMNANPC1
SCHEMBL25338900 0.75 NPC1 (0.36) ALDH1A1MAPTSMN1; SMN2CXCR3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023186069-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 石药集团中奇制药技术(石家庄)有限公司 2023-10-05 WO disclosed